25-Hydroxycholesterol induces lipopolysaccharide-tolerance and decreases a lipopolysaccharide-induced TNF-α secretion in macrophages

Atherosclerosis

Volumn 158, Issue 1, 2001, Pages 61-71

  Englund, Mikael C O ^a   Karlsson, Anne Li K ^a   Wiklund, Olov ^a   Bondjers, Göran ^a   Ohlsson, Bertil G ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Atherosclerosis; Gene expression; Oxysterol; TNF ; Transcription factor

Indexed keywords

25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 7 OXOCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; OXYSTEROL; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; HUMAN; HUMAN CELL; INCUBATION TIME; MACROPHAGE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; TRANSCRIPTION INITIATION;

CAROTID ARTERY DISEASES; CELLS, CULTURED; CHOLESTEROL; DNA-BINDING PROTEINS; DRUG TOLERANCE; ENDOTOXINS; HUMANS; HYDROXYCHOLESTEROLS; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; MACROPHAGES; NF-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034897288     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00407-5     Document Type: Article

References (52)

1. Low density lipoprotein oxidation and its pathobiological significance
2. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages
3. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
4. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
5. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
6. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines
7. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
8. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro
9. Expression of the CD36 homolog (FAT) in fibroblast cells: Effects on fatty acid transport
10. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner
11. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha
12. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway
13. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols
14. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
15. Regulation of the activity of the low density lipoprotein receptor in human fibroblasts
16. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages
17. Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase
18. Atherosclerosis and sterol 27-hydroxylase: Evidence for a role of this enzyme in elimination of cholesterol from human macrophages
19. Oxysterols and atherosclerosis
20. Inhibition of cellular cholesterol efflux by 25-hydroxycholesterol
21. Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols
22. Oxidation of cholesterol moiety of low density lipoprotein in the presence of human endothelial cells or Cu+2 ions: Identification of major products and their effects
23. Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper
24. Effect of the oxidation state of LDL on the modulation of arterial vasomotor response in vitro
25. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
26. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry
27. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production
28. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes
29. Interleukin-8 is chemotactic for vascular smooth muscle cells
30. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells
31. Function and activation of NF-kappa B in the immune system
32. The pathogenesis of atherosclerosis: A perspective for the 1990s
33. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: Evidence for a positive autoregulatory loop
34. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis
35. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
36. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion
37. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages
38. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B
39. Isolation of lymphocytes, granulocytes and macrophages
40. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
41. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
42. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
43. Quantitation of mRNA by the polymerase chain reaction
44. Defective translation of tumor necrosis factor mRNA in lipopolysaccharide-tolerant macrophages
45. Suppression of TNF-alpha mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-kappa B activation, but not at the level of protein kinase C or CD14 expression
46. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1
47. Sp1-mediated transcriptional activation is repressed by Sp3
48. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins
49. Sp3 represses transcription when tethered to promoter DNA or targeted to promoter proximal RNA
50. NF-kappaB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression
51. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport
52. Induction of Ikappa Balpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators